価格表

在庫・価格 : 2025年05月24日 04時28分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TLR5, Mouse-Mono(19D759.2)
データシート
NBP2-24787 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥96,000
(未発注)
追加

在庫・価格 : 2025年05月24日 04時28分 現在

Anti-TLR5, Mouse-Mono(19D759.2)

  • 商品コード:NBP2-24787
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fran巽ois S et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 2005 Mar;
Fran巽ois S et al
2005/01/01
PubMed
2 Kato K et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J. Immunol. 2012 Feb;188(4):2014-22
Kato K et al
2012/01/01
PubMed
3 Crellin NK et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 2005 Dec;175(12):8051-9
Crellin NK et al
2005/01/01
PubMed
4 Kauppila JH et al. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br. J. Cancer 2013 Feb;108(3):638-43
Kauppila JH et al
2013/01/01
PubMed
5 Faham A et al. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect. J. Immunol. 2010 Aug;185(3):1744-54
Faham A et al
2010/01/01
PubMed
6 Fukata M et al. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 2008 Feb;180(3):1886-94
Fukata M et al
2008/01/01
PubMed
7 Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
Wong CK et al
2007/01/01
PubMed
8 Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
Burgener IA et al
2008/01/01
PubMed
9 Wu J et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010 Mar;129(3):363-74
Wu J et al
2010/01/01
PubMed
10 Harman AN et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J. Immunol. 2013 Jan;190(1):66-79
Harman AN et al
2013/01/01
PubMed
11 Miller LS et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 2005 May;174(10):6137-43
Miller LS et al
2005/01/01
PubMed
12 Ha H et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta. J. Immunol. 2008 Feb;180(3):1382-9
Ha H et al
2008/01/01
PubMed
13 Deng J et al. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ. Res. 2009 Feb;104(4):488-95
Deng J et al
2009/01/01
PubMed
14 Helminen O et al. Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch. 2014 Jan;464(1):11-8
Helminen O et al
2014/01/01
PubMed
15 M辰kinen LK et al. Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. Oral Oncol. 2015 Jan;51(1):96-102
M辰kinen LK et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
16 Grimm M et al. Immunohistochemical detection of Helicobacter pylori without association of TLR5 expression in oral squamous cell carcinoma. J. Oral Pathol. Med. 2014 Jan;43(1):35-44
Grimm M et al
2014/01/01
Species: Human, Applications: IHC-P, ICC/IF, WB PubMed
17 Renkonen J et al. Expression of Toll-like receptors in nasal epithelium in allergic rhinitis. APMIS 2015 Aug;123(8):716-25
Renkonen J et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
18 Jouhi L et al. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma-an in vivo and in vitro study. Tumour Biol. 2015 Sep;36(10):7755-64
Jouhi L et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
19 Smith NJ et al. Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. J. Urol. 2011 Sep;186(3):1084-92
Smith NJ et al
2011/01/01
PubMed
20 Uchida M et al. Exhaustive exercise increases the TNF-α production in response to flagellin via the upregulation of toll-like receptor 5 in the large intestine in mice. Immunol. Lett. ;158(1-2):151-8
Uchida M et al
PubMed
21 Helminen O et al. Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior. Virchows Arch. 2016 Oct;469(4):465-70
Helminen O et al
2016/01/01
PubMed
22 Huhta H et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J. Histochem. Cytochem. 2016 08;64(8):470-82
Huhta H et al
2016/01/01
Species: Human, Applications: IHC-P PubMed
23 Kylm辰 AK et al. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma. Br. J. Cancer 2018 Jul;119(1):89-95
Kylm辰 AK et al
2018/01/01
Species: Human, Applications: IHC PubMed
24 Jeon YK et al. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination. Oncotarget 2016 Jul;7(27):41811-41824
Jeon YK et al
2016/01/01
Species: Human, Applications: DB PubMed
25 Carevic M et al. CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense. J Innate Immun 2016;8(4):362-73
Carevic M et al
2016/01/01
PubMed
26 Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
Larsson O et al
2018/01/01
Species: Mouse, Applications: Flow PubMed
27 Kylm辰 AK et al. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Exp Mol Pathol 2020 06;114:104435
Kylm辰 AK et al
2020/01/01
PubMed
28 Na BH et al. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-<i>&#x3BA;</i>B Activation in Human Myeloid Leukemia THP-1 Cells. Biomed Res Int 2018;2018:4319369
Na BH et al
2018/01/01
PubMed
29 Shang L et al. Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa. Contact Dermatitis 2020 Nov;83(5):347-360
Shang L et al
2020/01/01
PubMed
30 Kasurinen A et al. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome. Sci Rep 2019 08;9(1):12553
Kasurinen A et al
2019/01/01
PubMed
31 Ruuskanen M et al. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer 2019 Jun;19(1):624
Ruuskanen M et al
2019/01/01
PubMed
32 Kairaluoma V et al. Toll-like receptor 5 and 8 in hepatocellular carcinoma. APMIS 2021 Aug;129(8):470-479
Kairaluoma V et al
2021/01/01
PubMed
33 Beilmann-Lehtonen I et al. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Oncology 2021;99(9):589-600
Beilmann-Lehtonen I et al
2021/01/01
PubMed
34 Kitaura A et al. Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages. PLoS One 2021;16(1):e0245957
Kitaura A et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Fran巽ois S et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 2005 Mar;
    Fran巽ois S et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kato K et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J. Immunol. 2012 Feb;188(4):2014-22
    Kato K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Crellin NK et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 2005 Dec;175(12):8051-9
    Crellin NK et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kauppila JH et al. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br. J. Cancer 2013 Feb;108(3):638-43
    Kauppila JH et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Faham A et al. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect. J. Immunol. 2010 Aug;185(3):1744-54
    Faham A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Fukata M et al. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 2008 Feb;180(3):1886-94
    Fukata M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
    Wong CK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
    Burgener IA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wu J et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010 Mar;129(3):363-74
    Wu J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Harman AN et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J. Immunol. 2013 Jan;190(1):66-79
    Harman AN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Miller LS et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 2005 May;174(10):6137-43
    Miller LS et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ha H et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta. J. Immunol. 2008 Feb;180(3):1382-9
    Ha H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Deng J et al. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ. Res. 2009 Feb;104(4):488-95
    Deng J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Helminen O et al. Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch. 2014 Jan;464(1):11-8
    Helminen O et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    M辰kinen LK et al. Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. Oral Oncol. 2015 Jan;51(1):96-102
    M辰kinen LK et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Grimm M et al. Immunohistochemical detection of Helicobacter pylori without association of TLR5 expression in oral squamous cell carcinoma. J. Oral Pathol. Med. 2014 Jan;43(1):35-44
    Grimm M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF, WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Renkonen J et al. Expression of Toll-like receptors in nasal epithelium in allergic rhinitis. APMIS 2015 Aug;123(8):716-25
    Renkonen J et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Jouhi L et al. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma-an in vivo and in vitro study. Tumour Biol. 2015 Sep;36(10):7755-64
    Jouhi L et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Smith NJ et al. Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. J. Urol. 2011 Sep;186(3):1084-92
    Smith NJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Uchida M et al. Exhaustive exercise increases the TNF-&#x3B1; production in response to flagellin via the upregulation of toll-like receptor 5 in the large intestine in mice. Immunol. Lett. ;158(1-2):151-8
    Uchida M et al
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Helminen O et al. Nuclear localization of Toll-like receptor 5 in Barrett&#39;s esophagus and esophageal adenocarcinoma is associated with metastatic behavior. Virchows Arch. 2016 Oct;469(4):465-70
    Helminen O et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Huhta H et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J. Histochem. Cytochem. 2016 08;64(8):470-82
    Huhta H et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Kylm辰 AK et al. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma. Br. J. Cancer 2018 Jul;119(1):89-95
    Kylm辰 AK et al
    2018/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Jeon YK et al. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination. Oncotarget 2016 Jul;7(27):41811-41824
    Jeon YK et al
    2016/01/01
  • 備考:
    Species: Human, Applications: DB
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Carevic M et al. CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense. J Innate Immun 2016;8(4):362-73
    Carevic M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
    Larsson O et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Flow
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Kylm辰 AK et al. Elevated TLR5 expression in vivo and loss of NF-&#x3BA;&#x392; activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Exp Mol Pathol 2020 06;114:104435
    Kylm辰 AK et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Na BH et al. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-<i>&#x3BA;</i>B Activation in Human Myeloid Leukemia THP-1 Cells. Biomed Res Int 2018;2018:4319369
    Na BH et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Shang L et al. Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa. Contact Dermatitis 2020 Nov;83(5):347-360
    Shang L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Kasurinen A et al. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome. Sci Rep 2019 08;9(1):12553
    Kasurinen A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Ruuskanen M et al. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer 2019 Jun;19(1):624
    Ruuskanen M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kairaluoma V et al. Toll-like receptor 5 and 8 in hepatocellular carcinoma. APMIS 2021 Aug;129(8):470-479
    Kairaluoma V et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Beilmann-Lehtonen I et al. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Oncology 2021;99(9):589-600
    Beilmann-Lehtonen I et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Kitaura A et al. Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages. PLoS One 2021;16(1):e0245957
    Kitaura A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed